[Analysis of costs and consequences related to the persistence of Mirabegron and antimuscarinic treatments and their impact on quality of life in patients with overactive bladder in Spain: Results of a probabilistic model.]

CONCLUSIONS: The probabilistic model presented showed a greater persistence in patients treated with mirabegron compared to AM, leading to a positive impactin patients quality of life, as well cost savings to the NHS in Spain. PMID: 32633246 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32633246?dopt=Abstract

Source: Archivos Espanoles de Urologia - July 9, 2020 Category: Urology & Nephrology Tags: Arch Esp Urol Source Type: research